Litcius/Paper detail

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

Joe Y. Chang, Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay, Jianjun Zhang, Stephen G. Chun, Yasir Y. Elamin, Frank V. Fossella, George R. Blumenschein, Tina Cascone, Xiuning Le, J.V. Pozadzides, Anne S. Tsao, Vivek Verma, James W. Welsh, Aileen B. Chen, Mehmet Altan, Reza J. Mehran, Ara A. Vaporciyan, Stephen G. Swisher, Peter Balter, Junya Fujimoto, Ignacio I. Wistuba, Lei Feng, J Jack Lee, John V. Heymach

2023The Lancet225 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAblative caseLungRadiation therapyLung cancerImmunotherapyStage (stratigraphy)Open labelOncologyParenchymaRadiosurgeryRandomized controlled trialRadiologyPathologyInternal medicineSurgeryCancerBiologyPaleontologyLung Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers